Oncotherapy Announces Positive Pancreatic Cancer Vaccine Results
This article was originally published in PharmAsia News
Executive Summary
Kawasaki-based biotech firm Oncotherapy Science announced results of its vaccine OCV-101, an angiogenesis inhibitor for pancreatic cancer